Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors

Li, Charles ; Bonazzoli, Elena ; Bellone, Stefania ; Choi, Jungmin ; Dong, Weilai ; Menderes, Gulden ; Altwerger, Gary ; Han, Chanhee ; Manzano, Aranzazu ; Bianchi, Anna ; Pettinella, Francesca ; Manara, Paola ; Lopez, Salvatore ; Yadav, Ghanshyam ; Riccio, Francesco ; Zammataro, Luca ; Zeybek, Burak ; Yang-Hartwich, Yang ; Buza, Natalia ; Hui, Pei ; Wong, Serena ; Ravaggi, Antonella ; Bignotti, Eliana ; Romani, Chiara ; Todeschini, Paola ; Zanotti, Laura ; Zizioli, Valentina ; Odicino, Franco ; Pecorelli, Sergio ; Ardighieri, Laura ; Silasi, Dan-Arin ; Litkouhi, Babak ; Ratner, Elena ; Azodi, Masoud ; Huang, Gloria S ; Schwartz, Peter E ; Lifton, Richard P ; Schlessinger, Joseph ; Santin, Alessandro D

Proceedings of the National Academy of Sciences - PNAS, 2019-01, Vol.116 (2), p.619-624 [Periódico revisado por pares]

United States: National Academy of Sciences

Texto completo disponível